| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;44:271.)
© 2004 American Heart Association, Inc.
Scientific Contributions |
From the Franz Volhard Clinic and Max Delbrück Center for Molecular Medicine (S.V., G.D., K.E., F.C.L., M.G.), Charité University Hospitals, Humboldt University of Berlin, HELIOS Klinikum Berlin, Germany; Louisiana State University Health Sciences Center (M.G.), Department of Physiology, New Orleans; Department of Physiology (S.-Y.T.,Y.H.), Chinese University of Hong Kong, Shatin, China.
Correspondence to Maik Gollasch, MD, PhD, Franz Volhard Clinic, Wiltbergstraße 50, 13125 Berlin, Germany. E-mail gollasch{at}fvk-berlin.de or mgolla@lsuhsc.edu
| Abstract |
|---|
|
|
|---|
Key Words: muscle, smooth mesenteric arteries obesity hypertension, obesity
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Briefly, superior mesenteric arteries of male Sprague-Dawley rats (200 to 300 g, 6 to 8 weeks) were quickly transferred to cold (4°C) oxygenated (95% O2/5% CO2) physiological salt solution, and dissected into 2-mm rings as described previously, whereby periadventitial fat and connective tissue were either removed [() fat rings] or left intact [(+) fat rings].3,4 The periadventitial fat was removed with scissors,2 being careful not to damage the adventitia.5 In some experiments, 50% of the periadventitial fat was removed longitudinally along the ipsilateral side of the vessel ring with scissors; it was left intact on the contralateral side of the vessel ring. The organ bath was filled with physiological salt solution of the following composition (mol/L): 119 NaCl, 4.7 KCl, 1.2 KH2PO4, 25 NaHCO3, 1.2 Mg2SO4, 11.1 glucose, and 1.6 CaCl2 (95% O2 plus 5% CO2, 37°C, pH 7.4). The rings were placed in a small vessel wire myograph under an optimal resting tension of 2 mN.3,4 Tension is expressed as a percentage of the steady-state tension (100%) obtained with isotonic external 60 mmol/L KCl.
In the first series of experiments, the rings were exposed to increasing doses of serotonin (108 to 105 mol/L), endothelin I (109 to 107 mol/L), phenylephrine (3x109 to 105 mol/L), or U46619 (109 to 106 mol/L). In some experiments, we measured the concentration of serotonin in the bath solution of (+) fat and () fat vessels. After a 10-minute incubation period of () fat and (+) fat with 2 µmol/L serotonin, the serotonin concentration was not different in the bath solution between both groups (high-performance liquid chromatography analysis), indicating that the effects of perivascular fat are anticontractile and not because of partial degradation of the vasoconstrictor agent. In the second series of experiments, the effect of serotonin was investigated in rings pretreated with different K+ channel blockers. The effects were compared with contractions to 2 µmol/L serotonin 10 minutes before addition of the inhibitors. In the third series of experiments, the effects of cromakalim (100 nmol/L) were tested on 2 µmol/L serotonin- or 0.1 µmol/L U46619-induced contraction in rings following 10-minute exposure of serotonin or U46619.
Intracellular membrane potential was measured using sharp intracellular glass microelectrodes as previously described.6 The glass microelectrodes were prepared by means of a horizontal puller and filled with 3 mol/L KCl (tip resistance in the range of 40 to 60 M
). Impalement was from the adventitial side of each vessel.
All values are given as mean±SEM. Paired and unpaired Student t tests or ANOVA were used as appropriate. P<0.05 was considered statistically significant; n represents the number of arteries tested.
| Results |
|---|
|
|
|---|
|
Involvement of K+ Channels
We next tested the hypothesis that K+ channels are involved in this anticontractile effect. We challenged (+) fat rings and () fat rings (n=26) with 60 mmol/L KCl and 45 mmol/L KCl. Raising external K+ would be expected to diminish the effects of any K+ channel opener by substantially reducing the difference between the K+ equilibrium potential and the membrane potential.6,7 Figure 2A shows that the contractile responses of (+) fat vessels and () fat vessels to 60 mmol/L KCl were not significantly different. Figure IB shows that 45 mmol/L KCl induced smaller submaximal contractions, but the contractile responses of (+) fat vessels and () fat vessels to 45 mmol/L KCl were not significantly different. These findings demonstrate that excitation-contraction coupling in intact arteries and arteries lacking periadventitial fat remain functional and that the presence of periadventitial fat does not mechanically or otherwise alter the contractility of artery rings. In addition, the synthetic K+ channel opener cromakalim7,8 at 0.1 µmol/L (n=5) did not reduce 60 mmol/L KClinduced contractions in (+) fat vessels and () fat vessels (not shown). However, cromakalim at 0.1 µmol/L almost completely relaxed contractions of (+) fat vessels and () fat vessels to 2 µmol/L serotonin (Figure 2B). Thus, KATP channels are functional and membrane hyperpolarization of the smooth muscle cells can reverse serotonin-dependent contractions. The results suggest that the difference in response to serotonin between intact vessels and vessels without periadventitial fat is dependent on opening of K+ channels.
|
We next challenged (+) fat rings and () fat rings (n=6) with the thromboxane A2 analogue U46619. U46619 induces vascular contraction that is largely independent of vascular smooth muscle cell membrane potential changes. Thus, U44619-dependent contractions are resistant to opening of K+ channels in vascular smooth muscle cells.9 We generated dose-response curves to U44619 for intact (+) fat, n=6), and mesenteric artery rings without () fat, n=6). Figure 2C shows that the contractile responses of (+) fat vessels and () fat vessels to U44619 were not significantly different. In addition, cromakalim at 0.1 µmol/L had no effect on the contractile responses of (+) fat vessels and () fat vessels to 0.1 µmol/L U44619 (Figure 2D). These results are in line with our previous data indicating that the difference in contractile response to serotonin between intact vessels and vessels without periadventitial fat is dependent on opening of K+ channels.
Role of Kv Channels
To explore the nature of K+ channels involved in the fat-modulated response of mesenteric ring contraction, we tested different blockers of K+ channels present in rat mesenteric arteries. At 2 mmol/L, the Kv channel blocker 4-aminopyridine (4-AP)1012 virtually abolished the difference in response between intact (+) fat vessels and vessels without () fat (n=6) to serotonin (Figure 3A and Figure IIA online). The Kv channel blocker 3,4-diaminopyridine (3,4-DAP)13 at 1 mmol/L had similar effects (n=5, Figure 3B and Figure IIB). The small-conductance, Ca2+-activated K+ channel blocker apamin4 (1 µmol/L, n=6; Figure 4A and Figure IIC) and the KATP channel blocker glibenclamide10,14 (3 µmol/L, n=8; Figure 4B and Figure IID) were not effective. The inward rectifier K+ channel blocker Ba2+ (3 µmol/L)11 did not influence the anticontractile effect of fat (n=6, Figure III online). These results suggest that the difference in response to serotonin between intact vessels and vessels lacking periadventitial fat is most likely mediated by opening of Kv channels in vascular smooth muscle cells. Blockers of large-conductance, Ca2+-activated potassium channels, that is, iberiotoxin10,1416 (100 nmol/L, n=6, Figure IVA online) and tetraethylammonium10,14,16 (TEA; 1 mmol/L, n=6, Figure IVB), and tetrapentylammonium,17 which also blocks KATP channels,18 (2 µmol/L, n=6, not shown) enhanced serotonin-dependent contractions by 20% to 30% in both () fat and (+) fat rings. These results suggest that large-conductance Ca2+-activated K+ channels limit serotonin-dependent contractions of both (+) fat and () fat rings. However, the data also indicate that the difference in response to serotonin between intact (+) fat vessels and () fat vessels is not mediated by opening of large-conductance Ca2+-activated K+ channels in vascular smooth muscle cells.
|
|
To confirm the conclusion that 4-APsensitive, voltage-dependent K+ channels in arterial smooth muscle cells are involved in the anticontractile effects of fat, we measured the intracellular vascular smooth muscle cell membrane potential of (+) fat rings and () fat rings. Figure 3C shows that the intracellular membrane potentials were more hyperpolarized in (+) fat rings than in () fat rings (n=12 each). At 2 mmol/L, 4-AP virtually abolished the difference in intracellular membrane potential between intact (+) fat vessels and vessels without () fat (n=12 each).
| Discussion |
|---|
|
|
|---|
Inhibition of the contractile response to serotonin by fat depended on the amount of fat on each ring. The effects were not dependent on the endothelium. We studied the possible involvement of plasma membrane K+ channels in detail. We found that the anticontractile effect of periadventitial fat was not abolished by inhibition of KATP channels, small-conductance Ca2+-activated K+ channels, and inward rectifying K+ channels. However, we found that the anticontractile effect of periadventitial fat was abolished by inhibition of Kv channels. The resting membrane potential of smooth muscle cells in intact mesenteric artery rings was more hyperpolarized than in mesenteric artery rings without periadventitial fat, a difference that was abolished by Kv channel inhibition with 4-AP. Together, these results suggest that visceral periadventitial adipose tissue controls mesenteric arterial tone locally. We suggest that vascular smooth muscle cell Kv channels are involved in the anticontractile effects of periadventitial adipose tissue.
Patch-clamp studies have shown that slowly-inactivating Kv channels are expressed in smooth muscle cells of our preparation. These channels are sensitive to 4-APand 3,4-DAP1922 but not to TEA.22,23 In contrast to smooth muscle cells, Kv channels in adipocytes are rapidly-inactivating, sensitive to TEA,2426 and relatively resistant to 4-AP.2729 Ba2+-sensitive inward rectifying K+ have not been detected in adipocytes. In addition, we found that the intracellular membrane potential was more negative in smooth muscle cells of (+) fat rings compared with () fat rings, a difference that was abolished by 4-AP. We tried to measure the intracellular membrane potential in adipocytes of (+) fat rings. Unfortunately, this was technically impossible; this might also be the reason that there is no publication on intracellular membrane potential measurement in perivascular adipocytes. Taken together, the data are consistent with the idea that Kv channels in smooth muscle cells are involved in the anticontractile effect of adipose tissue.
In contrast to aorta, KATP channels were not involved in the mesenteric artery periadvential fat effect. A possible explanation is that KATP channels in aortic and mesenteric smooth muscle are different, as large-conductance KATP channels (
130 pS, in symmetric high K+) sensitive to intracellular [ATP] have been found in aorta but not in mesenteric arteries.3032 In rat mesenteric arteries, small-conductance KATP (KNDP) channels (
25 pS, in symmetric high K+) have been identified that are regulated by nucleoside diphosphates (UDP or GDP) and ATP acting from the inside.33,34 The molecular identity of the aortic and mesenteric KATP channels is not absolutely established. Two Kir6.x subunits have been cloned to date: Kir6.1 and Kir6.2 that differ in their single channel conductance. Three major types of sulfonylurea receptor have been cloned, SUR1, SUR2A, and SUR2B, although other splice variants also exist. The properties of a particular KATP channel are dependent on its subunit composition. KNDP channels seem to be equivalent to the Kir6.1/SUR2B channel,35 whereas the molecular composition of aortic KATP channels is less clear.3638 Based on their molecular diversity, it is possible that aortic and mesenteric KATP channels respond differently to ADRF. Alternatively, visceral periadventitial adipose tissue may produce a number of ADRFs or involve different ADRF receptors and intracellular second messengers to control vascular tone in different vascular beds.
Perspectives
We demonstrate an important functional role of periadventitial adipose tissue on mesenteric artery tone. We suggest that vascular smooth muscle cell Kv channels regulate the process. Identification of the putative ADRF may shed light on obesity-related hypertension and could possibly be of therapeutic importance.
| Acknowledgments |
|---|
Received March 25, 2004; first decision April 8, 2004; accepted June 18, 2004.
| References |
|---|
|
|
|---|
2. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002; 16: 10571063.
3. Tsang SY, Yao X, Wong CM, Au CL, Chen ZY, Huang Y. Contribution of Na+ -Ca2+ exchanger to pinacidil-induced relaxation in the rat mesenteric artery. Br J Pharmacol. 2003; 138: 453460.[CrossRef][Medline] [Order article via Infotrieve]
4. Tsang SY, Yao X, Chan HY, Wong CM, Chen ZY, Au CL, Huang Y. Contribution of K+ channels to relaxation induced by 17beta-estradiol but not by progesterone in isolated rat mesenteric artery rings. J Cardiovasc Pharmacol. 2003; 41: 413.[CrossRef][Medline] [Order article via Infotrieve]
5. Gonzalez MC, Arribas SM, Molero F, Fernandez-Alfonso MS. Effect of removal of adventitia on vascular smooth muscle contraction and relaxation. Am J Physiol Heart Circ Physiol. 2001; 280: H2876H2881.
6. Nelson MT, Huang Y, Brayden JE, Hescheler J, Standen NB. Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature. 1990; 344: 770773.[CrossRef][Medline] [Order article via Infotrieve]
7. Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989; 245: 177180.
8. McCarron JG, Quayle JM, Halpern W, Nelson MT. Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries. Am J Physiol. 1991; 261: H287H291.[Medline] [Order article via Infotrieve]
9. McPherson GA, Keily SG, Angus JA. Spasmolytic effect of cromakalim in dog coronary artery in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1991; 343: 519524.[Medline] [Order article via Infotrieve]
10. Gollasch M, Ried C, Bychkov R, Luft FC, Haller H. K+ currents in human coronary artery vascular smooth muscle cells. Circ Res. 1996; 78: 676688.
11. Robertson BE, Bonev AD, Nelson MT. Inward rectifier K+ currents in smooth muscle cells from rat coronary arteries: block by Mg2+, Ca2+, and Ba2+. Am J Physiol. 1996; 271: H696H705.[Medline] [Order article via Infotrieve]
12. Knot HJ, Nelson MT. Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol. 1998; 508 (Pt 1): 199209.
13. Robertson BE, Nelson MT. Aminopyridine inhibition and voltage dependence of K+ currents in smooth muscle cells from cerebral arteries. Am J Physiol. 1994; 267: C1589C1597.[Medline] [Order article via Infotrieve]
14. Nelson MT, Brayden JE. Regulation of arterial tone by calcium-dependent K+ channels and ATP-sensitive K+ channels. Cardiovasc Drugs Ther. 1993; 7 (Suppl 3): 605610.[CrossRef][Medline] [Order article via Infotrieve]
15. Schubert R, Nelson MT. Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacol Sci. 2001; 22: 505512.[CrossRef][Medline] [Order article via Infotrieve]
16. Rusch NJ, Liu Y, Pleyte KA. Mechanisms for regulation of arterial tone by Ca2+-dependent K+ channels in hypertension. Clin Exp Pharmacol Physiol. 1996; 23: 10771081.[Medline] [Order article via Infotrieve]
17. Bychkov R, Gollasch M, Ried C, Luft FC, Haller H. Effects of pinacidil on K+ channels in human coronary artery vascular smooth muscle cells. Am J Physiol. 1997; 273: C161C171.[Medline] [Order article via Infotrieve]
18. Kovacs RJ, Nelson MT. ATP-sensitive K+ channels from aortic smooth muscle incorporated into planar lipid bilayers. Am J Physiol. 1991; 261: H604H609.[Medline] [Order article via Infotrieve]
19. Lu Y, Zhang J, Tang G, Wang R. Modulation of voltage-dependent K+ channel current in vascular smooth muscle cells from rat mesenteric arteries. J Membr Biol. 2001; 180: 163175.[CrossRef][Medline] [Order article via Infotrieve]
20. Cox RH, Lozinskaya I, Dietz NJ. Differences in K+ current components in mesenteric artery myocytes from WKY and SHR. Am J Hypertens. 2001; 14: 897907.[CrossRef][Medline] [Order article via Infotrieve]
21. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol. 1990; 259: C3C18.[Medline] [Order article via Infotrieve]
22. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 268: C799C822.[Medline] [Order article via Infotrieve]
23. Smirnov SV, Aaronson PI. Ca(2+)-activated and voltage-gated K+ currents in smooth muscle cells isolated from human mesenteric arteries. J Physiol. 1992; 457: 431454.
24. Ramirez-Ponce MP, Mateos JC, Bellido JA. Human adipose cells have voltage-dependent potassium currents. J Membr Biol. 2003; 196: 129134.[CrossRef][Medline] [Order article via Infotrieve]
25. Russ U, Ringer T, Siemen D. A voltage-dependent and a voltage-independent potassium channel in brown adipocytes of the rat. Biochim Biophys Acta. 1993; 1153: 249256.[Medline] [Order article via Infotrieve]
26. Ringer E, Russ U, Siemen D. Beta(3)-adrenergic stimulation and insulin inhibition of non-selective cation channels in white adipocytes of the rat. Biochim Biophys Acta. 2000; 1463: 241253.[Medline] [Order article via Infotrieve]
27. Ramirez-Ponce MP, Mateos JC, Carrion N, Bellido JA. Voltage-dependent potassium channels in white adipocytes. Biochem Biophys Res Commun. 1996; 223: 250256.[CrossRef][Medline] [Order article via Infotrieve]
28. Ramirez-Ponce MP, Mateos JC, Bellido JA. Insulin increases the density of potassium channels in white adipocytes: possible role in adipogenesis. J Endocrinol. 2002; 174: 299307.[Abstract]
29. Wilson SM, Lee SC, Shook S, Pappone PA. ATP and beta-adrenergic stimulation enhance voltage-gated K current inactivation in brown adipocytes. Am J Physiol Cell Physiol. 2000; 279: C1847C1858.
30. Matzno S, Sato R, Takai H, Aida Y, Karasaki S, Oyaizu M, Nakamura N, Katori R. The effect of AL0671, a novel potassium channel opener, on potassium current in rat aortic smooth muscle cells. Gen Pharmacol. 1995; 26: 13271334.[Medline] [Order article via Infotrieve]
31. Janigro D, West GA, Gordon EL, Winn HR. ATP-sensitive K+ channels in rat aorta and brain microvascular endothelial cells. Am J Physiol. 1993; 265: C812C821.[Medline] [Order article via Infotrieve]
32. Quayle JM, Bonev AD, Brayden JE, Nelson MT. Pharmacology of ATP-sensitive K+ currents in smooth muscle cells from rabbit mesenteric artery. Am J Physiol. 1995; 269: C11121118.[Medline] [Order article via Infotrieve]
33. Zhang H, Bolton TB. Activation by intracellular GDP, metabolic inhibition and pinacidil of a glibenclamide-sensitive K-channel in smooth muscle cells of rat mesenteric artery. Br J Pharmacol. 1995; 114: 662672.[Medline] [Order article via Infotrieve]
34. Davie CS, Kubo M, Standen NB. Potassium channel activation and relaxation by nicorandil in rat small mesenteric arteries. Br J Pharmacol. 1998; 125: 17151725.[CrossRef][Medline] [Order article via Infotrieve]
35. Wang X, Wu J, Li L, Chen F, Wang R, Jiang C. Hypercapnic acidosis activates KATP channels in vascular smooth muscles. Circ Res. 2003; 92: 12251232.
36. Ren YJ, Xu XH, Zhong CB, Feng N, Wang XL. Hypercholesterolemia alters vascular functions and gene expression of potassium channels in rat aortic smooth muscle cells. Acta Pharmacol Sin. 2001; 22: 274278.[Medline] [Order article via Infotrieve]
37. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, Seino S. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med. 2002; 8: 466472.[CrossRef][Medline] [Order article via Infotrieve]
38. Suzuki M, Li RA, Miki T, Uemura H, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Ogura T, Seino S, Marban E, Nakaya H. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res. 2001; 88: 570577.
This article has been cited by other articles:
![]() |
G. A. Payne, H. G. Bohlen, U. D. Dincer, L. Borbouse, and J. D. Tune Periadventitial adipose tissue impairs coronary endothelial function via PKC-{beta}-dependent phosphorylation of nitric oxide synthase Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H460 - H465. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Greenstein, K. Khavandi, S. B. Withers, K. Sonoyama, O. Clancy, M. Jeziorska, I. Laing, A. P. Yates, P. W. Pemberton, R. A. Malik, et al. Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients Circulation, March 31, 2009; 119(12): 1661 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Chatterjee, L. L. Stoll, G. M. Denning, A. Harrelson, A. L. Blomkalns, G. Idelman, F. G. Rothenberg, B. Neltner, S. A. Romig-Martin, E. W. Dickson, et al. Proinflammatory Phenotype of Perivascular Adipocytes: Influence of High-Fat Feeding Circ. Res., February 27, 2009; 104(4): 541 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Galvez-Prieto, J Bolbrinker, P Stucchi, A I de las Heras, B Merino, S Arribas, M Ruiz-Gayo, M Huber, M Wehland, R Kreutz, et al. Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue J. Endocrinol., April 1, 2008; 197(1): 55 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Rosito, J. M. Massaro, U. Hoffmann, F. L. Ruberg, A. A. Mahabadi, R. S. Vasan, C. J. O'Donnell, and C. S. Fox Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study Circulation, February 5, 2008; 117(5): 605 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Malinowski, M. A. Deja, K. S. Golba, T. Roleder, J. Biernat, and S. Wos Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor Eur. J. Cardiothorac. Surg., February 1, 2008; 33(2): 225 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verlohren, M. Niehoff, L. Hering, N. Geusens, F. Herse, A. N. Tintu, A. Plagemann, F. LeNoble, R. Pijnenborg, D. N. Muller, et al. Uterine Vascular Function in a Transgenic Preeclampsia Rat Model Hypertension, February 1, 2008; 51(2): 547 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thalmann and C. A. Meier Local adipose tissue depots as cardiovascular risk factors Cardiovasc Res, September 1, 2007; 75(4): 690 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fesus, G. Dubrovska, K. Gorzelniak, R. Kluge, Y. Huang, F. C. Luft, and M. Gollasch Adiponectin is a novel humoral vasodilator Cardiovasc Res, September 1, 2007; 75(4): 719 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takemori, Y.-J. Gao, L. Ding, C. Lu, L.-Y. Su, W.-S. An, C. Vinson, and R. M.K.W. Lee Elevated Blood Pressure in Transgenic Lipoatrophic Mice and Altered Vascular Function Hypertension, February 1, 2007; 49(2): 365 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. U. Momin, N. Melikian, A. M. Shah, D. J. Grieve, S. B. Wheatcroft, L. John, A. El Gamel, J. B. Desai, T. Nelson, C. Driver, et al. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance Eur. Heart J., October 1, 2006; 27(19): 2294 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Gao, K. Takemori, L.-Y. Su, W.-S. An, C. Lu, A. M. Sharma, and R. M.K.W. Lee Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion Cardiovasc Res, July 15, 2006; 71(2): 363 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Galvez, J. de Castro, D. Herold, G. Dubrovska, S. Arribas, M. C. Gonzalez, I. Aranguez, F. C. Luft, M. P. Ramos, M. Gollasch, et al. Perivascular Adipose Tissue and Mesenteric Vascular Function in Spontaneously Hypertensive Rats Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1297 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Davis, G. Valacchi, E. Pagnin, Q. Shao, H. B. Gross, L. Calo, and W. Yokoyama Walnuts Reduce Aortic ET-1 mRNA Levels in Hamsters Fed a High-Fat, Atherogenic Diet J. Nutr., February 1, 2006; 136(2): 428 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Benkirane, E. C. Viel, F. Amiri, and E. L. Schiffrin Peroxisome Proliferator-Activated Receptor {gamma} Regulates Angiotensin II-Stimulated Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase in Blood Vessels In Vivo Hypertension, January 1, 2006; 47(1): 102 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Barandier, J.-P. Montani, and Z. Yang Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1807 - H1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rahmouni, M. L.G. Correia, W. G. Haynes, and A. L. Mark Obesity-Associated Hypertension: New Insights Into Mechanisms Hypertension, January 1, 2005; 45(1): 9 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Fernandez-Alfonso Regulation of Vascular Tone: The Fat Connection Hypertension, September 1, 2004; 44(3): 255 - 256. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |